Abstract
In an effort to determine the optimal dose and frequency of chronic endoscopic variceal sclerotherapy, a prospective randomized controlled study comparing two treatment schedules of sclerotherapy was carried out over a 21-month period. Patients with variceal hemorrhage were randomly assigned to receive sclerotherapy at weekly intervals using injection volumes of >15 cc at each treatment or at mean intervals of three days using volumes of <10 cc per treatment. Esophageal perforation occurred in three patients (15%) in the small-dose, frequent-injection group as compared to none in the large-dose weekly treatment group (P=0.07), leading to premature termination of the study. The mean time to rebleeding was significantly shorter in the small-dose, frequent-treatment group (P=0.05). Variceal obliteration was achieved in a mean of 66% of patients in both groups with no difference in the time to obliteration or the frequency of other complications. Sclerotherapy offered at less than weekly intervals is less effective and is associated with an increased frequency of serious and life threatening complications.
Similar content being viewed by others
References
Reynolds TB: What to do about esophageal varices. N Engl J Med 309:1575–1577, 1983
Kage M, Korula J, Harada A, et al: The effect of sodium tetradecyl sulfate endoscopic variceal sclerotherapy on the esophagus; a prospective clinical and histopathological study. J Clin Gastroenterol 9:635–643, 1987
Westaby D, Melia WM, MacDougall BRD, et al: Injection sclerotherapy for oesophageal varices. A prospective randomized controlled trial of different treatment schedules. Gut 25:129–132, 1984
Sarin SK, Sachdev G, Nanda R, et al: Comparison of two treatment time schedules for endoscopic sclerotherapy: A prospective randomized controlled study. Gut 27:710–713, 1986
Cello JP, Grendell JH, Crass RA, et al: Endoscopic sclerotherapy versus portocaval shunt in patients with severe cirrhosis and acute variceal hemorrhage. N Engl J Med 316:11–15, 1987
The Copenhagen Esophageal Varices Sclerotherapy Project. Sclerotherapy after first variceal hemorrhage in cirrhosis. A randomized multicenter trial. N Engl J Med 311:1594–1600, 1984
Jensen D, Machicado GA, Silpa M: Esophageal varix hemorrhage and sclerotherapy—animal studies. Endoscopy 18:18–22, 1986
Korula J, Yellin AE, Yamada S, et al: A prospective randomized controlled comparison of endoscopic variceal sclerotherapy and portal systemic shunt surgery in recurrent variceal hemorrhage in Child's class A cirrhotics. Gastroenterology 92:1745, 1987 (abstract)
Pugh RNH, Murray-Lyon IM, Dawson JL, et al: Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646–649, 1973
Korula J, Balart LA, Radvan G, et al: A prospective randomized controlled trial of chronic esophageal variceal sclerotherapy. Hepatology 5:584–589, 1985
Soderlund C, Ihre T: Endoscopic sclerotherapy versus conservative management of bleeding esophageal varices. A 5 year prospective controlled trial of emergency and long term treatment. Acta Chir Scand Suppl 524:vl-23, 1985
Larson AW, Cohen H, Zweiban B, et al: A prospective controlled trial of acute esophageal variceal sclerotherapy. JAMA 255:497–500, 1986
Cohen J: Statistical Power Analysis for the Behavioral Sciences. New York, Academic Press, 1977, pp 179–213
Snedecor GW, Cochran WG: Statistical Methods, 6th ed. Ames, Iowa, Iowa State University Press, 1967
Peto R, Peto J: Asymptotically efficient rank invariant procedures J R Stat Soc Ser A. 135:185–207, 1972
Macdougall BRD, Westaby D, Theodossi A, et al: Increased long-term survival in variceal hemorrhage using injection sclerotherapy. Lancet 1:124–127, 1982
Terblanche J, Bornman PC, Khan D, et al: Failure of repeated injection sclerotherapy to improve long term survival after oesophageal variceal bleeding. A five year prospective controlled trial. Lancet 2:1328–1332, 1983
Iso Y, Kitano S, Higashi H, et al: A prospective randomized trial comparing two injection methods for endoscopic injection sclerotherapy — large volume and small volume of 5% ethanolamine oleate. Gastroenterology 92:1449, 1987 (abstract)
Sarin SK, Nanda R, Vij JC, Anand BS: Esophageal ulceration after sclerotherapy—a complication or accompaniment? Endoscopy 18:44–45, 1986
Kitano S, Koyangi N, Iso Y, et al: Prevention of recurrence of esophageal varices after endoscopic injection sclerotherapy with ethanolamine oleate. Hepatology 7:810–815, 1987
Pitcher JL: Variceal sclerotherapy: The combination of thrombosclerosis and the intentional removal of the distal esophageal mucosa to treat variceal bleeding to prevent variceal recurrence. Hepatology 7:964–966, 1987
Tabibian N, Alpert E: Refractory sclerotherapy-induced esophageal strictures. Ann Intern Med 106:59–60, 1987
Korula J, Pandya K, Yamada S: Perforation of the esophagus after endoscopic variceal sclerotherapy; incidence and clues to pathogenesis. Dig Dis Sci 34:324–329, 1989
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Akriviadis, E., Korula, J., Gupta, S. et al. Frequent endoscopic variceal sclerotherapy increases risk of complications. Digest Dis Sci 34, 1068–1074 (1989). https://doi.org/10.1007/BF01536376
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01536376